You have no items in your shopping cart.
On Promotion
Elisa Kits Promotion 0
Products on Sale 0
Category
Proteins and Peptides 275055
Species Host
Human 498
E. coli 158
Rabbit 76
Plant 4
Bovine 3
Insect 1
Yeast 1
Tested Applications
WB 42869
ELISA 22256
SDS-PAGE 15107
Blocking 11025
IHC 2121
MS 2019
HPLC 620
CLIA 406
LF 390
EIA 382
Cell Culture 288
FA 198
IP 98
IF 88
ChIP 57
DOT 49
IA 38
FC 27
Functional Studies 24
In vitro 16
In vivo 14
ATPase Activity Assay 9
CBA 6
Control 6
ICC 6
Purification 6
FACS 2
GICA 2
IAC 2
IB 2
ICA 2
PCR 2
SBR 2
2D-PAGE 1
CoIP 1
DARTs Assay 1
Double Diffusion 1
ELISpot 1
FLISA 1
HAI 1
ID 1
IEP 1
RIA 1
SB 1
Turbidimetry 1
cDNA Synthesis 1
Reactivity
Human 16849
Mouse 6089
Rat 4647
Monkey 1685
Bovine 1676
Porcine 1085
Canine 675
Gallus 657
Rabbit 425
Zebrafish 387
Virus 299
Sheep 297
Other 62
Bacteria 36
Hamster 10
Goat 9
Feline 8
Plant 8
Guinea pig 7
Equine 5
Camelus 3
E. coli 3
H. pylori 2
Parasite 2
Primate 2
Protozoa 2
Rat and Mouse 2
A. thaliana 1
Algae 1
Aspergillus 1
Ferret 1
Fungi 1
HCMV 1
HSV-1 1
Jellyfish 1
Marmoset 1
Rabies virus 1
Yeast 1
Predicted Reactivity
Human 13150
Mouse 1978
Rat 670
Conjugation
Unconjugated 6994
Biotin 286
FITC 72
HRP 69
TRITC 46
Texas Red 31
Agarose 25
AP 11
PE 4
RPE 2
APC 1
Cy5 1
Elite Fluor 488 1
Elite Fluor 647 1
Matched Antibody
Yes 33
No 275022
Biologically Active
Yes 2356
Featured Product
Yes 17978
Has Publications
Yes 97
No 274958
Filtered Products
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.6 KDa. Observed: 55-70 KDa, reducing conditions
Human
Gln67-Ser225
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 74 KDa. Observed: 90-95 KDa, reducing conditions
Human
Val18-Leu680
C-6His
1 mg, 10 μg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 36.4 KDa. Observed: 32-50 KDa, reducing conditions
Mouse
His18-Phe339
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 52.2 KDa. Observed: 80-110 KDa, reducing conditions
Human
Gln67-Ala528
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 45.96 KDa. Observed: 41-50 KDa, reducing conditions
Human
Met1-Pro390
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 63.1 KDa. Observed: 80-110 KDa, reducing conditions
Human
Asp20-Tyr337
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.4 KDa. Observed: 58 KDa, reducing conditions
Human
Met1-His453
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.5 KDa. Observed: 24 KDa, reducing conditions
Human
Cys30-Pro224
C-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.1 KDa. Observed: 13-19 KDa, reducing conditions
Human
Met22-Pro141
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.8 KDa. Observed: 45-55 KDa, reducing conditions
Human
Gly21-Ser162
C-Fc
10 μg, 50 μg, 500 μg, 1 mg